Summit Global Investments »

Catalyst Pharmaceutical Partners shares owned by Summit Global Investments

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 91k 16.82
2023-09-30 $1.1M 97k 11.69
2023-06-30 $329k 25k 13.43
2021-09-30 $689k 130k 5.30
2021-06-30 $331k 58k 5.76

More positions owned by Summit Global Investments

RBB Sgi Us Large Cap (SGLC)
RBB Sgi Diversi Tac (DYTA)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vertex Pharmaceuticals Incorporated (VRTX)
Alphabet Cap Stk Cl A (GOOGL)
Accenture Plc Ireland Shs Class A (ACN)
Hershey Company (HSY)
Merck & Co (MRK)
Kimberly-Clark Corporation (KMB)
Electronic Arts (EA)
Anthem (ELV)
Prudential Financial (PRU)

View all positions for Summit Global Investments

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners